These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28126517)

  • 1. Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
    Barniol-Xicota M; Kwak SH; Lee SD; Caseley E; Valverde E; Jiang LH; Kim YC; Vázquez S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):759-763. PubMed ID: 28126517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing an atomic-resolution model of human P2X7 receptor followed by pharmacophore modeling to identify potential inhibitors.
    Ahmadi M; Nowroozi A; Shahlaei M
    J Mol Graph Model; 2015 Sep; 61():243-61. PubMed ID: 26298810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human.
    Caseley EA; Muench SP; Baldwin SA; Simmons K; Fishwick CW; Jiang LH
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3164-7. PubMed ID: 26099538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
    Allsopp RC; Dayl S; Schmid R; Evans RJ
    Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
    Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
    Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR development of novel P2X7 receptor antagonists for the treatment of pain: part 2.
    Brumfield S; Matasi JJ; Tulshian D; Czarniecki M; Greenlee W; Garlisi C; Qiu H; Devito K; Chen SC; Sun Y; Bertorelli R; Ansell J; Geiss W; Le VD; Martin GS; Vellekoop SA; Haber J; Allard ML
    Bioorg Med Chem Lett; 2011 Dec; 21(24):7287-90. PubMed ID: 22078214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists.
    Rudolph DA; Alcazar J; Ameriks MK; Anton AB; Ao H; Bonaventure P; Carruthers NI; Chrovian CC; De Angelis M; Lord B; Rech JC; Wang Q; Bhattacharya A; Andres JI; Letavic MA
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3157-63. PubMed ID: 26099534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
    Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
    Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and pharmacological evaluation of a novel series of adamantyl cyanoguanidines as P2X
    O'Brien-Brown J; Jackson A; Reekie TA; Barron ML; Werry EL; Schiavini P; McDonnell M; Munoz L; Wilkinson S; Noll B; Wang S; Kassiou M
    Eur J Med Chem; 2017 Apr; 130():433-439. PubMed ID: 28279849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for subtype-specific inhibition of the P2X7 receptor.
    Karasawa A; Kawate T
    Elife; 2016 Dec; 5():. PubMed ID: 27935479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists.
    Caseley EA; Muench SP; Fishwick CW; Jiang LH
    Biochem Pharmacol; 2016 Sep; 116():130-9. PubMed ID: 27481062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel purine-based heterocyclic P2X7 receptor antagonists.
    Kwak SH; Lee WG; Lee YJ; Lee SD; Kim YC; Ko H
    Bioorg Chem; 2015 Aug; 61():58-65. PubMed ID: 26123174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and in vitro Evaluation of P2X7 Antagonists.
    T Pournara D; Durner A; Kritsi E; Papakostas A; Zoumpoulakis P; Nicke A; Koufaki M
    ChemMedChem; 2020 Dec; 15(24):2530-2543. PubMed ID: 32964578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
    de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
    Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
    Bin Dayel A; Evans RJ; Schmid R
    Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
    Park JH; Lee GE; Lee SD; Ko H; Kim YC
    Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334.
    Lord B; Ameriks MK; Wang Q; Fourgeaud L; Vliegen M; Verluyten W; Haspeslagh P; Carruthers NI; Lovenberg TW; Bonaventure P; Letavic MA; Bhattacharya A
    Eur J Pharmacol; 2015 Oct; 765():551-9. PubMed ID: 26386289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of P2X7 antagonists with a focus on CNS indications.
    Rech JC; Bhattacharya A; Letavic MA; Savall BM
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of a novel series of urea, thiourea and guanidine derivatives as P2X
    Wong ECN; Reekie TA; Werry EL; O'Brien-Brown J; Bowyer SL; Kassiou M
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2439-2442. PubMed ID: 28408229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.